Only about 16% of people eligible for lung cancer screening undergo the annual low-dose CT scan, according to Moffitt Cancer Center. The low screening…
A national panel of 15 mesothelioma specialists across surgery, medical oncology, radiation oncology and pathology reached a consensus and issued new guidelines for surgery.
The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This…
In a significant development for mesothelioma patients, the U.S. Food and Drug Administration has accepted priority review for a new supplemental Biologics License Application.
Dr. Rodney Landreneau is joining the renowned Thoracic Surgical Program at Tampa General Hospital. He spent decades caring for patients with pleural mesothelioma…
Patients diagnosed with pleural mesothelioma are better managed and survive longer when treated at an integrated specialty center, according to a study by…
Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option…
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Reviewed & Fact-Checked
This page was reviewed by:
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
